Tetrahydrobiopterin - ≥98%, high purity , CAS No.17528-72-2, Activator of L-Phenylalanine hydroxylase

Item Number
T305191
Grouped product items
SKUSizeAvailabilityPrice Qty
T305191-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$294.90
T305191-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$491.90

Basic Description

Synonymstetrahydrobiopterin | 17528-72-2 | 5,6,7,8-tetrahydrobiopterin | 2-amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydropteridin-4(3H)-one | CHEBI:15372 | 2-amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydro-3H-pteridin-4-one | 5,6,7,8-Tetrahydro-2-amino-6-(1,2-dihydroxypro
Specifications & PurityMoligand™, ≥98%
Storage TempStore at 2-8°C
Shipped InWet ice
GradeMoligand™
Action TypeACTIVATOR
Mechanism of actionActivator of L-Phenylalanine hydroxylase

Associated Targets(Human)

PAH Tclin Phenylalanine-4-hydroxylase (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 2-amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydro-3H-pteridin-4-one
INCHI InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)
InChi Key FNKQXYHWGSIFBK-UHFFFAOYSA-N
Canonical SMILES CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O
Isomeric SMILES CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O
PubChem CID 135402045
Molecular Weight 241.25

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Safety and Hazards(GHS)

Signal Warning
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

H302:Harmful if swallowed

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

Related Documents

References

1. Bélanger-Quintana A, Burlina A, Harding CO, Muntau AC.  (2011)  Up to date knowledge on different treatment strategies for phenylketonuria..  Mol Genet Metab,  104 Suppl  (3): (S19-25).  [PMID:21967857]
2. Cronin SJF, Seehus C, Weidinger A, Talbot S, Reissig S, Seifert M, Pierson Y, McNeill E, Longhi MS, Turnes BL et al..  (2018)  The metabolite BH4 controls T cell proliferation in autoimmunity and cancer..  Nature,  563  (7732): (564-568).  [PMID:30405245]

Solution Calculators